A new report by the European Commission has revealed that the costs of implementing major regulations for the European chemical industry doubled between 2004 and 2014 to around €10 billion/year. A second phase of the study will now compare these costs with those in other regions, looking in more detail at competitiveness on a broader scale. The report, entitled Cumulative Cost Assessment (CCA) is part of the EC’s ‘Better Regulation’ process. It is available online at: http://ec.europa.eu/DocsRoom/documents/17784/attachments/1/translations/.
Ecolab, the parent company of Nalco Water, has made an undisclosed minority equity investment in Aquatech International. Based in Canonsburg, Aquatech is privately owned and employs about 1,500 across the world, offering industrial and infrastructure water treatment services in areas including raw water treatment, ion exchange, membrane processes, wastewater recycle and reuse, zero liquid discharge, industrial concentration and desalination. The company said that this would improve Nalco Water’s capabilities in enabling customers “to minimise net water usage and maximise process performance and productivity”.
Cambrex has completed and validated its new $50 million production and warehousing expansion at Charles City, Iowa. The facility will add 70 m3 of glass lined and Hastelloy reactors, plus 6 m2 Hastelloy agitated filter dryers. It will be capable of handling potent APIs at an Occupational Exposure Limit of down to 1 μg/m3. The cGMP warehouse will provide storage for 2,720 pallets and segregated 2-8°C refrigerated storage for 360 pallet spaces and also features Distributed Control System monitoring and control for temperature and humidity.
AMRI has completed the €315 million acquisition of the Italian API maker Euticals in a deal that was originally announced on 5 May. The company said that this makes it “one of the largest independent developers and suppliers of API to the pharmaceutical industry”, giving it “an established custom synthesis presence in key European markets” and bringing it significantly closer to its target of $1 billion/year in revenues by 2018.
Under a new distribution agreement, Univar USA is now exclusively distributing Angus Chemical’s complete line of nitroalkanes and speciality additive products to various US markets. These include: paint and coatings; personal care; adhesives and sealants; household, industrial and institutional cleaning; inks; rubber; oil and gas; and, water treatment. Metalworking fluids and the life sciences are not included. Angus is the only company to nitroalkanes and their derivatives, having made them for some 80 years.
Lonza has acquired Triangle Research Labs (TRL) of Research Triangle Park, North Carolina, from PBM Capital Group. Terms were not disclosed. Founded in 2012, TRL has four facilities and supplies hepatocytes for use in testing of the in vitro evaluation of metabolism, drug-drug interactions, drug transporter activity, toxicity of drug candidates and other applications. This will complement Lonza’s existing activity in cell systems for the bioresearch market, the two companies said.
Dow Chemical is to lay off about 2,500 employees, 4% of its workforce, as it takes control of Dow Corning, hitherto a 50-50 joint venture with Corning in silicones. Whilst the two transactions are separate, this is closely linked to Dow’s planned mega-merger with DuPont, which has continued to move forward.
Two of the world’s top four chemical distributors have made acquisitions in Africa in the past month. Global market leader has acquired South African speciality distributor Warren Chem, while the number four company IMCD has bought Chemicals and Solvents (EA) in Kenya.
Published: April 18, 2016
Western suppliers of pharmaceutical fine chemical suppliers are doing well right now, but will it last? We report from DCAT Week ‘16